Press Releases

and/or
572 News Releases found
Advanced Practice Providers (APP) nurse practitioner Amy Devigne and a lung cancer survivor
Memorial Sloan Kettering Plans New Pavilion to Ensure Greater Access to Care for All People in New York and Beyond

To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side.
MSK Awards & Appointments March 2022

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK Awards & Appointments February 2022

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Marie-Josée and Henry R. Kravis
Memorial Sloan Kettering Announces $100M Gift to Create The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to Spur the Next Generation of Pre-Clinical Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) today announced the creation of The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to spur the next revolution of pre-clinical research, discovery, and treatment.
Memorial Sloan Kettering President and CEO Craig B. Thompson, MD
Memorial Sloan Kettering President and CEO Craig B. Thompson, MD to Step Down

Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor.
Nikolaus Schultz, PhD
Pivotal Memorial Sloan Kettering Cancer Center Study Provides Insights into the Genomic Basis of Cancer Metastasis

A new study from Memorial Sloan Kettering Cancer Center (MSK) provides important insights into cancer metastasis.  
Ghassan Abou-Alfa, MD
Immunotherapy Combination Significantly Improves Overall Survival for People with Advanced Liver Cancer Compared with Current Standard of Care

New study results found that patients who received a combination of the immunotherapy drugs durvalumab and tremelimumab significantly improved overall survival
MSK Awards & Appointments January 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Rémy Evard
Memorial Sloan Kettering Cancer Center Appoints Rémy Evard as Chief Digital Officer and Head of Technology

Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Fiona and Stanley Druckenmiller
Memorial Sloan Kettering Cancer Center Announces the Creation of the Fiona and Stanley Druckenmiller Presidential Innovation Fund

Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.